2 active warrant series covering 39,261,171 shares (~25.9% potential dilution); nearest expiry 2026-12-13.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| warrant | $0.10 | Dec 13, 2026 74d | 5.9M | OTM | 3.9% | C$593K | Auto |
| warrant | $0.05 | Sep 22, 2028 723d | 33.3M | OTM | 22.0% | C$1.7M | Auto |
Basis: Current shares & price vs as-filed warrant terms.
1 option grant covering 900,000 shares (~0.6% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $0.07 | Oct 26, 2026 26d | 900K | OTM | 0.6% | C$63K | Auto |
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
151,504,215 shares outstanding, plus 39,261,171 from warrants and 900,000 from options — a fully diluted 191,665,386 shares, or ~26.5% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
2 active warrant series covering 39,261,171 shares (~25.9% potential dilution); nearest expiry 2026-12-13.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| warrant | $0.10 | Dec 13, 2026 74d | 5.9M | OTM | 3.9% | C$593K | Auto |
| warrant | $0.05 | Sep 22, 2028 723d | 33.3M | OTM | 22.0% | C$1.7M | Auto |
Basis: Current shares & price vs as-filed warrant terms.
1 option grant covering 900,000 shares (~0.6% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $0.07 | Oct 26, 2026 26d | 900K | OTM | 0.6% | C$63K | Auto |
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
151,504,215 shares outstanding, plus 39,261,171 from warrants and 900,000 from options — a fully diluted 191,665,386 shares, or ~26.5% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
